American National Bank & Trust’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2K Hold
207
﹤0.01% 454
2026
Q1
$13.4K Sell
207
-153
-43% -$10.8K ﹤0.01% 461
2025
Q4
$24.2K Buy
360
+62
+21% +$4.17K ﹤0.01% 436
2025
Q3
$21.9K Buy
+298
New +$19.8K ﹤0.01% 455
2025
Q2
Sell
-56
Closed -$3.57K 680
2025
Q1
$3.57K Buy
+56
New +$3.25K ﹤0.01% 533

Other funds holding HALO

American National Bank & Trust's HALO Position: Q2 2026 in Review

American National Bank & Trust held its Halozyme (HALO) position steady in Q2 2026 at 207 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

American National Bank & Trust first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. The position peaked at $24.2K in Q4 2025. 172 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • American National Bank & Trust held 207 shares of Halozyme worth $16.2K as of Q2 2026.
  • American National Bank & Trust left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #454 holding.
  • American National Bank & Trust first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • American National Bank & Trust's Halozyme position peaked at $24.2K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.